Kaul Malvika, Barbieri Christopher M, Kerrigan John E, Pilch Daniel S
Department of Pharmacology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854-5635, USA.
J Mol Biol. 2003 Mar 7;326(5):1373-87. doi: 10.1016/s0022-2836(02)01452-3.
2-Deoxystreptamine (2-DOS) aminoglycoside antibiotics bind specifically to the central region of the 16S rRNA A site and interfere with protein synthesis. Recently, we have shown that the binding of 2-DOS aminoglycosides to an A site model RNA oligonucleotide is linked to the protonation of drug amino groups. Here, we extend these studies to define the number of amino groups involved as well as their identities. Specifically, we use pH-dependent 15N NMR spectroscopy to determine the pK(a) values of the amino groups in neomycin B, paromomycin I, and lividomycin A sulfate, with the resulting pK(a) values ranging from 6.92 to 9.51. For each drug, the 3-amino group was associated with the lowest pK(a), with this value being 6.92 in neomycin B, 7.07 in paromomycin I, and 7.24 in lividomycin A. In addition, we use buffer-dependent isothermal titration calorimetry (ITC) to determine the number of protons linked to the complexation of the three drugs with the A site model RNA oligomer at pH 5.5, 8.8, or 9.0. At pH 5.5, the binding of the three drugs to the host RNA is independent of drug protonation effects. By contrast, at pH 9.0, the RNA binding of paromomycin I and neomycin B is coupled to the uptake of 3.25 and 3.80 protons, respectively, with the RNA binding of lividomycin A at pH 8.8 being coupled to the uptake of 3.25 protons. A comparison of these values with the protonation states of the drugs predicted by our NMR-derived pK(a) values allows us to identify the specific drug amino groups whose protonation is linked to complexation with the host RNA. These determinations reveal that the binding of lividomycin A to the host RNA is coupled to the protonation of all five of its amino groups, with the RNA binding of paromomycin I and neomycin B being linked to the protonation of four and at least five amino groups, respectively. For paromomycin I, the protonation reactions involve the 1-, 3-, 2'-, and 2"'-amino groups, while, for neomycin B, the binding-linked protonation reactions involve at least the 1-, 3-, 2', 6'-, and 2"'-amino groups. Our results clearly identify drug protonation reactions as important thermodynamic participants in the specific binding of 2-DOS aminoglycosides to the A site of 16S rRNA.
2-脱氧链霉胺(2-DOS)氨基糖苷类抗生素特异性结合16S rRNA A位点的中心区域并干扰蛋白质合成。最近,我们已经表明2-DOS氨基糖苷类与A位点模型RNA寡核苷酸的结合与药物氨基的质子化有关。在此,我们扩展这些研究以确定参与的氨基数量及其身份。具体而言,我们使用pH依赖的15N NMR光谱来测定新霉素B、巴龙霉素I和硫酸青紫霉素A中氨基的pK(a)值,所得pK(a)值范围为6.92至9.51。对于每种药物,3-氨基的pK(a)最低,新霉素B中该值为6.92,巴龙霉素I中为7.07,硫酸青紫霉素A中为7.24。此外,我们使用缓冲液依赖的等温滴定量热法(ITC)来确定在pH 5.5、8.8或9.0时三种药物与A位点模型RNA寡聚物络合时连接的质子数。在pH 5.5时,三种药物与宿主RNA的结合与药物质子化效应无关。相比之下,在pH 9.0时,巴龙霉素I和新霉素B与RNA的结合分别与摄取3.25和3.80个质子相关,硫酸青紫霉素A在pH 8.8时与RNA的结合与摄取3.25个质子相关。将这些值与我们通过NMR得出的pK(a)值预测的药物质子化状态进行比较,使我们能够确定其质子化与宿主RNA络合相关的特定药物氨基。这些测定结果表明,硫酸青紫霉素A与宿主RNA的结合与其所有五个氨基的质子化相关,巴龙霉素I和新霉素B与RNA的结合分别与四个和至少五个氨基的质子化相关。对于巴龙霉素I,质子化反应涉及1-、3-、2'-和2'''-氨基,而对于新霉素B,则结合相关的质子化反应至少涉及1-、3-、2'、6'-和2'''-氨基。我们的结果清楚地表明药物质子化反应是2-DOS氨基糖苷类与16S rRNA A位点特异性结合中重要的热力学参与者。